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Introduction: Inorganic materials are widely used in medical devices, such as artificial hearts, 
vessels, and joints, in stents, and as nanocarriers for drug-delivery systems. Carbon nanomaterials 
are of particular interest due to their biological inertness and their capability to accommodate 
molecules. Several attempts have been proposed, in which carbon nanomaterials are used as 
nanocarriers for the systemic delivery of drugs.
Materials and methods: We developed a drug-delivery system in which oxidized single-
walled carbon nanohorns (oxSWNHs) were immobilized on a titanium (Ti) surface using 
material-binding peptides to enable localized drug delivery. For this purpose, we utilized a 
bispecific peptidic aptamer comprising a core sequence of a Ti-binding peptide and a SWNH-
binding peptide to immobilize oxSWNHs on Ti.
Results: Scanning electron microscopy was used to confirm the presence of oxSWNHs adsorbed 
onto the Ti surface, and a quartz crystal microbalance was used to evaluate the binding process 
during oxSWNH adsorption. The oxSWNHs-ornamented Ti substrate was nontoxic to cells and 
released biologically active dexamethasone over a sustained period.
Conclusion: This oxSWNHs-immobilized system can be used to modify the surface of Ti in 
implants and be loaded with drugs that stimulate osteogenesis and bone regeneration.
Keywords: drug carrier, drug delivery, carbon nanomaterial, carbon nanohorn, peptide aptamer
Introduction
Controlled surface modification of substrates is critical for the development of 
biomaterials that can interact with cells.1–4 Surface modifications can be classified as 
physical, chemical, or biological.5 In the chemical approach, various types of drug 
compounds are used as components of modifiers, which induce highly specific reac-
tions in the biological system. To develop a functionalized surface that can release 
drugs into the microenvironment adjacent to the materials, we must first establish a 
system to load the drug and slowly release it from the carrier.
Titanium (Ti) is widely used as a biomaterial for dental implants, artificial joints, and 
stents.6 For developing next-generation titanium implants, several modification methods 
have been proposed to reduce the time required for osseointegration. These methods 
include the use of sintered metal beads, surface blasting, acid or alkaline treatment, 
anodization, and ion implantation.7–10 Surface chemistry is a pivotal factor in the regu-
lation of interactions between the biomaterial and cells/tissue.11–14 In addition to these 
physical and chemical methods, modification using natural proteins, such as collagen, 
cell-adhesive molecules, or growth factors, has also been attempted.5 For example, 
Kashiwagi et al3 ornamented Ti surfaces with modified bone-morphogenetic protein 
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(BMP) that had an affinity for Ti. Different methodologies 
have been designed to control drug release from Ti.15,16 One 
strategy relies on surface modification. Usually, the rough 
Ti surface contributes to enhanced drug loading as compared 
with plane Ti. For example, a Ti plate containing nanopores 
shows enhanced drug-loading capability.17 Another approach 
involves attachment of therapeutic molecules directly to the 
Ti surface. Therapeutic molecules are chemically attached to 
a pure Ti surface18 or to self-assembled monolayers, which act 
as a glue.19 Additionally, drug coatings comprising drugs and 
hydroxyapatite20 or polymer21 show controlled drug-release 
profiles in vitro and in vivo.
Carbon nanomaterials have potential applications as 
carriers in drug-delivery systems22–29 because of their favor-
able characteristics, including stability, inertness, and a large 
surface area for drug loading.30–33 A single-walled carbon 
nanohorn (SWNH) is a spherical aggregate with a diameter 
of ~50 nm to ~100 nm and comprising ~2,000 single-walled 
graphene tubules with a nonuniform diameter of 2 nm to 5 nm 
and a length of 40 nm to 50 nm.34 SWNHs have an extensive 
surface area and intertubule interstices that can accommodate 
large amounts of adsorbed molecules.35 Moreover, the surface 
area can be enlarged by oxidization, which causes the forma-
tion of nanowindows in the SWNH walls,36 through which a 
variety of small molecules can infiltrate into the inner space.37 
Oxidized SWNHs (oxSWNHs) can open two to four holes 
that allow the passage of various materials, including drugs, 
which can then be stored inside the aggregate.37,38 The ability 
of oxSWNHs to load and release drugs, such as dexametha-
sone (DEX),28 doxorubicin,39 and cisplatin,40,41 has also been 
shown, and no acute toxicity has been reported for SWNHs 
in animals,33,42,43 highlighting their utility for biological 
applications.
In this study, we used a Ti-binding peptide (TBP-1)44 and 
SWNH-binding peptide (NHBP-1)45 to immobilize a drug-
delivery system on a Ti surface. TBP-1 is a material-binding 
peptide isolated as an aptamer against Ti. Although originally 
isolated as a 12-mer peptide (RKLPDAPGMHTW), further 
mutational analyses revealed that a hexapeptide sequence 
(RKLPDA; named minTBP-1) is sufficient to mediate 
binding. The arginine, proline, and aspartate in this sequence 
(R1, P4, and D5, respectively) are critical for Ti recogni-
tion, suggesting that electrostatic interactions constitute the 
predominant binding force.46 NHBP-1 is a 12-amino acid 
aptamer (DYFSSPYYEQLF) isolated as a specific SWNH 
binder using a peptide phage system. Non-covalent modifica-
tion with a conjugate of polyethylene glycol and NHBP-1 
enhances the dispersibility of hydrophobic oxSWNHs under 
aqueous conditions.41
Recent studies of peptide aptamers have highlighted the 
importance of valency on the part of the displayed peptide 
for target affinity with the conjugate. Multivalent display of 
peptide aptamers increases the affinity of the conjugate for the 
target,47,48 and in one instance, multivalency increased conju-
gate adsorption.2 We speculated that TBP–NHBP generated 
by fusing minTBP-1 and NHBP-1 would be adsorbed onto 
oxSWNHs, enabling a multivalent display of minTBP-1 on 
oxSWNHs and allowing the latter to be adsorbed onto the Ti 
surface. To test this possibility, we synthesized TBP–NHBP 
and developed a method for immobilizing oxSWNHs on 
the Ti surface using this peptide. We also tested the ability 
of DEX-loaded oxSWNHs immobilized on a Ti surface to 
release the drug in a sustained fashion and examined how 
this affects the activation of preosteoblasts grown on the 
functionalized Ti surface.
Materials and methods
adsorption of oxsWNhs onto Ti plates
oxSWNHs were prepared by oxidation of as-grown SWNHs 
in dry air, with the temperature increased from room tem-
perature to 550°C at a rate of 1°C/min.49 oxSWNHs were 
dispersed in dimethylformamide (DMF) at 10 mg/mL, and 
after sonication at 130 W (Bioruptor® UCD-200; Cosmo Bio 
Co. Ltd, Tokyo, Japan), 5 µL of the oxSWNH suspension was 
diluted by adding 175 µL of 10% DMF in water (purified with 
a Biocel A10 filter; Merck Millipore, Billerica, MA, USA), 
followed by brief sonication. A 20-µL volume of TBP–NHBP 
(RKLPDAGGDYFSSPYYEQLF; 1 mM in DMF) was added 
to the solution, which was vortexed for 10 min at room 
temperature. TBP–NHBP comprised the peptide aptamers 
minTBP-1 (RKLPDA) and NHBP-1 (DYFSSPYYEQLF) 
connected via a GG linker. The custom peptide was con-
structed via solid-phase peptide synthesis by Anygen Co. Ltd 
(Gwangju, Korea). The final concentrations of oxSWNHs 
and TBP–NHBP in the mixture were 0.25 mg/mL and 
100 µM, respectively. Ti plates (Japan Industrial Specifica-
tion H4600; 99.9 mass % Ti, 10×10×1 mm; Shinkinzoku 
Co. Ltd., Osaka, Japan) were incubated for 1 h at room tem-
perature in 500 µL of the oxSWNHs/TBP–NHBP mixture in 
24-well culture plates (BD Biosciences, Sparks, MD, USA), 
washed three times with water filtered through a 0.22-µm 
membrane (Millipore), and then dried under vacuum for 8 h. 
The ratio of TBP–NHBP to oxSWNHs was evaluated in pilot 
experiments under various conditions. oxSWNHs adsorbed 
onto Ti plates were quantified using an electronic balance 
(UMX2; Mettler-Toledo, Billerica, MA, USA) and observed 
by scanning electron microscopy (SEM; VE-8800, Keyence, 
Osaka, Japan).
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Quartz crystal microbalance (QcM) 
measurements
The binding of oxSWNHs to the Ti surface was evaluated 
with a QCM (QCM-D300; Q-Sense AB, Götenborg, Sweden) 
and a Ti sputter-coated QCM sensor that was first cleaned for 
10 min using an ultraviolet/ozone cleaner surface-treatment 
system (ProCleaner™, BioForce Nanosciences, Inc., Salt 
Lake City, UT, USA). Measurements were performed at 
25°C, and data were collected at 14.8 MHz. The sensor was 
first equilibrated with the mixture containing oxSWNHs and 
TBP–NHBP1 peptide (100 µM) in 10% DMF, followed by 
washing with 0.5 mL of 10% DMF. The second and sub-
sequent layers were formed in the same manner. Data were 
analyzed using Q-tools software (https://qtools.com).
cell viability
Cell viability was qualitatively analyzed by fluorescence 
microscopy. MC3T3-E1 cells (ATCC) were seeded on Ti plates 
(10×10×1 mm) in 24-well plates (BD Biosciences) at a density 
of 1×105 cells/well and cultured for 48 h. MC3T3E-1 cells 
were maintained in α-minimal essential medium (α-MEM; 
Gibco®, Thermo Fisher Scientific, Grand Island, NY, USA) 
supplemented with 10% fetal bovine serum (FBS; JRH Biosci-
ence, Lenexa, KS, USA), 100 µg/mL penicillin (Banyu Phar-
maceutical Co., Tokyo, Japan), and 100 U/mL streptomycin 
(Meiji Seika Kaisha, Tokyo, Japan) in continuous culture at 
37°C under a humidified atmosphere with 5% CO
2
 and 95% 
air. After three washes with phosphate-buffered saline (PBS; 
Gibco-BRL, Carlsbad, CA, USA), adherent cells were stained 
with 2 µM calcein-AM and 4 µM propidium iodide (Dojindo 
Laboratories, Kumamoto, Japan) in PBS and washed twice with 
PBS. The stained cells were photographed under a DMLP reflec-
tion microscope (Leica Microsystems, Bensheim, Germany) 
equipped with a DC480 or DFC350 FX digital camera.
adsorption of DeX-oxsWNhs onto 
Ti plates
oxSWNHs (500 µg/mL) were dispersed by sonication in 
10% DMF, and cell-culture-grade DEX (1,000 µg/mL; 
Sigma-Aldrich, St Louis, MO, USA) in 10% DMF was 
added at a volumetric ratio of 1:1. The mixture was vortexed 
for 10 min and incubated overnight at room temperature. 
DEX-oxSWNHs were mixed with TBP–NHBP and vortexed 
for 10 min. Ti plates (10×10×1 mm) in 24-well culture plates 
were incubated for 1 h at room temperature in 500 µL of the 
above mixture, washed three times with water filtered through 
a 0.22-µm membrane (Millex-GS; Millipore), and dried 
under vacuum for 8 h. The amount of DEX was quantified 
with [3H]-DEX (1.48 TBq/mmol; Amersham Bioscience, 
Piscataway, NJ, USA) using an LS6500 scintillation counter 
(Beckman Coulter, Fullerton, CA, USA).
analysis of in vitro release of DeX from 
DeX-oxsWNhs on a Ti surface
DEX-oxSWNHs were prepared as described using [3H]-
DEX and incubated at 37°C in PBS, Roswell Park Memorial 
Institute (RPMI) 1640 medium (Gibco), or α-MEM supple-
mented with 5% FBS, 100 µg/mL penicillin, and 100 U/mL 
streptomycin. Samples were collected at predetermined 
time points, and the amount of [3H]-DEX released into the 
supernatant was quantified using a scintillation counter. 
For cumulative-release experiments, the supernatant was 
replaced with fresh medium at each time point.
DeX-responsive promoter assay
An expression vector containing the luciferase-reporter gene 
under the control of a DEX-responsive element (pBV2-
MMTV-LUC) was gifted by Drs H Noguchi and I Abe of 
the University of Shizuoka (Shizuoka, Japan).50 ST2 cells 
(RIKEN BioResource Center) were seeded at a density of 
2.5×104 cells/well on Ti plates (10×10×1 mm) in 24-well 
plates. ST2 cells were maintained in RPMI 1640 supple-
mented with 10% FBS, 100 µg/mL penicillin, and 100 U/mL 
streptomycin in continuous culture at 37°C under a humidi-
fied atmosphere with 5% CO
2
 and 95% air. After incubating 
for 1 day, cells were co-transfected with pBV2-MMTV-LUC 
and thymidine kinase promoter-driven Renilla luciferase 
DNA (Promega Corporation, Fitchburg, WI, USA) using 
FuGENE6 (Promega). After an additional 24 h, luciferase 
activity was measured using the dual-luciferase reporter assay 
system (Promega) and an AutoLumat LB953 luminometer 
(Berthold Technologies, Oak Ridge, TN, USA) according to 
the manufacturer’s instructions.
alkaline phosphatase (alP) assay
MC3T3-E1 cells were seeded at a density of 1.0×104 cells/
well on Ti plates (10×10×1 mm) in 24-well plates and grown 
until they reached 70%–80% confluence. The culture medium 
was changed to a differentiation-inducing medium consisting 
of α-MEM supplemented with 5% FBS, 100 U/mL penicillin, 
100 µg/mL streptomycin, 50 µM ascorbic acid, 10 mM 
β-glycerophosphate, and 20 ng/mL recombinant human bone 
morphogenetic protein-4 (Genzyme/TECHNE, Cambridge, 
MA, USA). The cells were incubated for 5, 7, 10, or 14 days, 
during which time the medium was refreshed every 3 days. 
Medium changes were performed carefully to ensure that 
oxSWNHs or DEX-oxSWNHs adhering to the Ti plates 
were not disturbed and removed along with the medium. 
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To evaluate ALP activity, the medium was removed, and 
cells were washed three times with Tris-buffered saline 
(TBS) comprising 20 mM Tris (pH 7.4) and 150 mM NaCl. 
The cells were harvested by scraping them into 200 µL TBS 
containing 1% Triton X-100 on ice and sonicated on ice 
for 5 min. The resulting cell lysates were centrifuged at 
16,100 g for 20 min at 4°C, and the supernatant (50 µL) was 
mixed with p-nitrophosphate. The amount of p-nitrophenol 
released after 45 min was measured by spectrophotometry 
(405 nm) using a Model 550 microplate reader (Bio-Rad 
Laboratories Inc., Hercules, CA, USA). The protein content 
of the supernatant was assayed by the Lowry method using 
a bicinchoninic acid protein assay kit (Pierce, Rockford, IL, 
USA). ALP activity was expressed as the amount of released 
p-nitrophenol normalized to total protein concentration.
statistical analysis
Differences between groups were evaluated by one-way 
analysis of variance. Any P-values ,0.05 and ,0.01 were 
considered significant.
Results
Immobilization of oxsWNhs/TBP–NhBP 
on a Ti surface
We generated TBP–NHBP (RKLPDAGGDYFSSPYYEQLF), 
a fusion of minTBP-1 and NHBP-1 connected via a GG 
linker, to mediate the binding of oxSWNHs to the Ti surface 
(Figure 1). TBP–NHBP was mixed with oxSWNHs in 10% 
DMF to obtain the dispersed oxSWNHs/TBP–NHBP com-
plex, which was adsorbed onto the Ti surface by incubating 
Ti plates in dispersed solutions of the complex. Three samples 
[oxSWNHs without peptide (oxSWNHs), a mixture of 
minTBP-1 and oxSWNHs (oxSWNHs/TBP), and a mixture 
of NHBP and oxSWNHs (oxSWNHs/NHBP)] were adsorbed 
onto the Ti plates and served as the controls. Figure 2A shows 
the SEM image of the oxSWNHs/TBP-NHBP-adsorbed 
particles on the Ti surface. When oxSWNHs were adsorbed 
onto Ti plates with TBP–NHBP, the weight of the plate 
increased relative to the controls (Figure 2F). By contrast, 
the adsorption of oxSWNHs without TBP–NHBP onto 
the Ti surface was negligible (Figure 2B and F). When 
oxSWNHs alone were incubated with the Ti plates, aggre-
gates formed that were nonuniformly adsorbed on the plate 
surface (Figure 2B). Additionally, we used a TBP–NHBP 
variant containing an arginine (R) to alanine (A) mutation 
in the minTBP-1 sequence AKLPDA [TBP(R-A)-NHBP] to 
determine whether the minTBP-1 sequence in TBP–NHBP 
was effective for Ti binding. oxSWNHs did not uniformly 
adsorb to Ti in the presence of TBP(R-A)-NHBP (Figure 2C 
and F), consistent with a previous report showing that loss 
of the charged R residue reduced the binding of minTBP-1 
to Ti.44,47 Additionally, the dispersibility of oxSWNHs might 
have been reduced by the R-to-A substitution. These results 
indicated that the minTBP-1 sequence promoted binding of 
oxSWNHs to Ti. Additionally, oxSWNHs did not uniformly 
adsorb to the Ti surface when mixed with TBP or NHBP 
alone (Figure 2D–F), indicating that TBP–NHBP conferred 
the binding characteristics of minTBP-1 on oxSWNHs.
To investigate the ability of TBP–NHBP to promote 
adsorption of oxSWNHs onto the Ti surface, we used a 
QCM to monitor changes in the resonance frequency (f) 
and dissipation (D) of the Ti plate. Initial infusion of an 
oxSWNHs/TBP–NHBP solution into the QCM measurement 
cell reduced f by ~65 Hz, with this response plateauing within 
1 min and ameliorated by subsequent infusion of a wash 
buffer, indicating that oxSWNHs/TBP-NHBP were bound 
to the Ti surface (Figure 3A). When the cell chamber was 
refilled with an oxSWNHs/TBP–NHBP solution, f declined, 
whereas D increased. By contrast, injection of oxSWNHs 
alone reduced f by only 9 Hz, indicating a weak association 
with the Ti sensor (Figure 3B).
We then investigated whether oxSWNHs must be pre-
mixed with TBP–NHBP for efficient adsorption to Ti by 
testing whether pre-adsorption of TBP–NHBP alone to Ti 
facilitated oxSWNH immobilization through interaction of 
the latter with the NHBP part of the peptide on the solid 
phase. To this end, we injected TBP–NHBP alone onto 
Ti plates, followed by injection of oxSWNHs. This did not 
result in adsorption of oxSWNHs to Ti (Figure 3C), and 
moreover, there was no adsorption by injection of oxSWNHs 
after oxSWNHs/TBP–NHBP were injected and allowed 
to adsorb to the Ti sensor (Figure 3D). These results dem-
onstrated the necessity of pre-mixing TBP–NHBP and 
oxSWNHs for adsorption of oxSWNHs onto the Ti surface. 
???????
????????
????????
????????
????????????????????
??????
Figure 1 schematic representation of oxsWNhs containing the TBP–NhBP peptide 
complex (oxSWNHs/TBP–NHBP) on the Ti surface. oxSWNHs were modified by 
artificial peptide aptamers against SWNH (NHBP-1) and Ti (minTBP-1).
Abbreviations: oxsWNhs, oxidized single-walled carbon nanohorns; TBP, 
Ti-binding peptide; NhBP-1, sWNh-binding peptide.
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When TBP–NHBP alone was used, adsorption onto Ti plates 
was observed (Figure 3E); however, use of oxSWNHs/
TBP–NHBP resulted in an increase in D (Figure 3F). Even 
if cleaning was performed prior to each flow of oxSWNHs/
TBP-NHBP, an increase in D was observed, although when 
TBP-NHBP only was used, a minimal increase in D was 
observed. It is possible that this resulted due to the unstable 
adsorption of some of the oxSWNHs to Ti in the chamber. 
Therefore, the minTBP-1 portion of TBP–NHBP also contrib-
uted to the immobilization of oxSWNHs on the Ti surface.
We then investigated whether oxSWNHs/TBP–NHBP 
on Ti was toxic to cells by culturing MC3T3-E1 cells on 
oxSWNHs/TBP–NHBP on the Ti plates. The live/dead assay 
using calcein/propidium-iodide staining revealed good cell 
viability after 2 days of culture (Figure 4A and B). These 
results demonstrated that uncoated Ti and oxSWNHs/
TBP–NHBP on Ti exhibited comparable effects on cell 
viability. SWNHs do not contain contaminating metals, as 
they are prepared by laser ablation from pure graphite without 
a metallic catalyst, which reduces the risk of toxicity.33
In vitro release of DeX from DeX-
oxsWNhs/TBP–NhBP on Ti
Controlled release from a drug-carrier complex is an impor-
tant property of drug-delivery systems. In vitro binding and 
release of the anti-inflammatory glucocorticoid DEX by 
oxSWNHs was previously reported.28 Here, we evaluated the 
in vitro drug-release potential of oxSWNHs on Ti according 
to the cumulative doses of [3H]-DEX released from DEX-
oxSWNHs on Ti plates in PBS, α-MEM, and RPMI medium 
at 37°C (Figure 5). The initial release of DEX from Ti was 
slower in α-MEM or RPMI medium than in PBS. Addition-
ally, DEX from Ti in α-MEM or RPMI medium was released 
in a sustained fashion for up to 2 weeks.
Biological activity of DeX released from 
DeX-oxsWNhs/TBP–NhBP on Ti
DEX is a synthetic agonist of glucocorticoid receptor 
(GR), which is a nuclear receptor that binds to glucocor-
ticoid response elements (GREs) to activate target-gene 
transcription.51 We examined the responsiveness of GREs 
to DEX released from DEX-oxSWNHs/TBP–NHBP on Ti 
using the reporter plasmid pBV2-MMTV-LUC containing 
a luciferase gene under the control of GREs.50 To this end, 
we transfected ST2 cells with pBV2-MMTV-LUC, followed 
by incubation with DEX-oxSWNHs/TBP–NHBP, DEX, or 
oxSWNHs/TBP–NHBP on Ti. DEX and DEX-oxSWNHs/
TBP–NHBP activated luciferase expression, with the latter 
having a greater effect, whereas the cells alone and oxSWNHs/
TBP–NHBP had no effect (Figure 6). Additionally, DEX-
oxSWNHs/TBP-NHBP showed an even greater activation 
than DEX alone on Ti.
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Figure 2 scanning electron micrographs of Ti plates functionalized with oxsWNhs/TBP–NhBP. (A–E) Ti plates were functionalized with oxsWNhs/TBP–NhBP (A), 
oxsWNhs (B), oxsWNhs/TBP(r-a)-NhBP (C), oxsWNhs/TBP (D), or oxsWNhs/NhBP (E). The inset shows magnified sections. Black scale: 20 µm; red scale: 2 µm. 
(F) adsorption amounts measured using an electronic balance.
Abbreviations: oxsWNhs, oxidized single-walled carbon nanohorns; TBP, Ti-binding peptide; NhBP-1, sWNh-binding peptide.
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DEX promotes the differentiation of preosteoblasts 
into mature osteoblasts, a process characterized by ALP 
expression.52 Additionally, preosteoblastic MC3T3-E1 cells 
treated with DEX show upregulated expression of ALP, as 
well as BMP-4, which is a potent inducer of osteoblast dif-
ferentiation and bone formation.53,54 Here, we found that treat-
ment of MC3T3-E1 cells with DEX-oxSWNHs/TBP–NHBP 
adsorbed on Ti in the presence of BMP-4 increased ALP 
expression from day 5 to day 14, whereas oxSWNHs/
TBP–NHBP had no effect (Figure 7). Moreover, on day 14, 
the activity was higher for DEX-oxSWNHs/TBP–NHBP 
adsorbed on Ti as compared with that observed in control 
samples (P,0.05). Our results indicated that DEX released 
from DEX-oxSWNHs on Ti plates was biologically active.
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Figure 3 Time-dependent changes in f and D determined using a QcM. (A–F) oxsWNhs/TBP–NhBP (A), oxsWNhs (B), TBP–NhBP (C), oxsWNhs/TBP–NhBP (D), 
TBP–NhBP (E), and TBP–NhBP and oxsWNhs/TBP–NhBP (F) deposited on a Ti-coated sensor. Values on the longitudinal axis represent negative Δf and positive ΔD 
values. changes associated with oxsWNhs/TBP–NhBP, oxsWNhs, and TBP–NhBP adsorption are indicated by green, gray, and purple lines, respectively. green, gray, 
and purple arrowheads indicate the time points at which oxsWNhs/TBP–NhBP, oxsWNhs, and TBP–NhBP, respectively, were infused into the measurement chamber. 
Vs represent the time points at which the wash solution (10% DMF) was infused.
Abbreviations: oxsWNhs, oxidized single-walled carbon nanohorns; TBP, Ti-binding peptide; NhBP-1, sWNh-binding peptide; DMF, dimethylformamide.
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Discussion
Ti and its alloys are frequently used for bone and dental 
implants, and their junction with adjacent bone tissue is 
paramount. Ti-based materials are also used as scaffolds for 
biomolecules that control cellular activities, such as adhe-
sion, differentiation, and proliferation.5 Ti implants should 
ideally have osteoinduction capacity, representing the ability 
to stimulate the formation of new bone from progenitor cells. 
Various nanomaterials, including carbon nanotubes (CNTs), 
multi-walled CNTs, and SWNHs, promote bone formation 
by interacting with osteoblasts.55–57 In the present work, 
we combined the TBP–NHBP peptide with oxSWNHs to 
obtain dispersed oxSWNHs/TBP–NHBP complexes, which 
were adsorbed onto the Ti surface. Incorporation of the 
TBP–NHBP peptide conferred the binding characteristics 
of minTBP-1 to oxSWNHs and mediated their uniform 
bidimensional adsorption onto the Ti surface. NHBP-1 
binds to oxSWNHs, but has low solubility, whereas fusion 
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Figure 4 Viability of Mc3T3-e1 cells cultured for 2 days on oxsWNhs/TBP–NhBP on Ti. Viable cell counts were determined relative to cells grown on uncoated Ti (none). 
(A) live (green, left panel) and dead (red, right panel) cells were stained with calcein-aM and propidium iodide, respectively. White scale: 100 µm. (B) counts of live cells 
on uncoated Ti and oxsWNhs/TBP–NhBP-conjugated Ti. error bars indicate standard deviation (n=4).
Abbreviations: oxsWNhs, oxidized single-walled carbon nanohorns; TBP, Ti-binding peptide; NhBP-1, sWNh-binding peptide.
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Figure 5 In vitro release of DeX from DeX-oxsWNhs/TBP–NhBP on Ti. Time course 
of cumulative release of [3h]-DeX from DeX-oxsWNhs/TBP–NhBP on Ti plates in 
PBs (blue line), rPMI medium/5% FBs (green line), and α-MeM/5% FBs (red line) at 37°c 
over 14 days. The inset shows cumulative release of DeX from DeX-oxsWNhs/TBP–
NhBP on Ti plates in PBs (blue line), rPMI medium/5% FBs (green line), and α-MeM/5% 
FBs (red line) at 37°c for 24 hours. error bars indicate standard deviation (n=3).
Abbreviations: DeX, dexamethasone; PBs, phosphate-buffered saline; rPMI, 
roswell Park Memorial Institute; α-MeM, α-minimal essential medium; oxsWNhs, 
oxidized single-walled carbon nanohorns; TBP, Ti-binding peptide; NhBP-1, sWNh-
binding peptide.
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Figure 6 effects of DeX-oxsWNhs on gr transcriptional activity. sT2 cells were 
transfected with pBV2-MMTV-lUc and incubated with oxsWNhs/TBP–NhBP, 
DeX, or DeX-oxsWNhs/TBP–NhBP on Ti plates. error bars indicate standard 
deviation (n=5). **P,0.01.
Abbreviations: oxsWNhs, oxidized single-walled carbon nanohorns; TBP, Ti-
binding peptide; NhBP-1, sWNh-binding peptide; DeX, dexamethasone.
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Figure 7 effects of DeX-oxsWNhs on alP activity. Mc3Ts-e1 cells were cultured 
with oxsWNhs/TBP–NhBP, DeX, or DeX-oxsWNhs/TBP–NhBP on Ti plates 
for 5, 7, 10, and 14 days. error bars indicate standard deviation (n=5). **P,0.01; 
*P,0.05.
Abbreviations: alP, alkaline phosphatase; DeX, dexamethasone; oxsWNhs, 
oxidized single-walled carbon nanohorns; TBP, Ti-binding peptide; NhBP-1, sWNh-
binding peptide.
with highly soluble minTBP-1 enhances the dispersibility of 
oxSWNHs. This is the likely reason for the uniform adsorp-
tion of oxSWNHs onto the Ti surface without aggregation. 
We also showed that oxSWNHs/TBP–NHBP were adsorbed 
onto the Ti surface by monitoring the changes in f and D 
in a Ti plate, observing that pre-mixing TBP–NHBP and 
oxSWNHs was important for oxSWNHs adsorption. The 
decrease in f and increase in D were not saturated within 
the observation range, suggesting that surface treatment can 
be readily controlled. Furthermore, oxSWNHs/TBP–NHBP 
immobilized on Ti were nontoxic to cultured cells, even 
after 2 days of culture and in contrast with CNTs.58 SWNHs 
contain no metal impurities, because SWNHs are synthesized 
through laser ablation or arc discharge using pure graphite 
rods without any metal catalysts.59,60 Therefore, SWNHs have 
negligible toxicity both in vitro and in vivo,33,42,43,61 which 
facilitates fabrication of the functionalized nanoplatforms 
for biomedical applications with low toxicity.
To assess the potential of oxSWNHs on Ti for drug 
delivery, we compared the release of the anti-inflammatory 
glucocorticoid DEX in PBS, α-MEM, and RPMI medium at 
37°C. DEX was released from Ti at a slower rate in α-MEM 
and RPMI than in PBS; moreover, in cell-culture media, the 
release was sustained for up to 14 days. Variable solubility 
of DEX in PBS and cell-culture media could account for 
the differences in the release profiles. Additionally, GREs 
were activated by DEX and especially DEX-oxSWNHs/
TBP–NHBP, with adsorption of the latter onto Ti increasing 
ALP activity in MC3T3-E1 cells relative to control samples 
on day 14. Therefore, DEX was not delivered in a single 
burst at the implantation site, but was steadily released for 
a sustained effect.
The results of the in vitro assays indicated that DEX 
released from DEX-oxSWNHs on Ti plates was biologically 
active. To date, there have been no studies on the effective-
ness of DEX delivered by oxSWNHs/TBP–NHBP on Ti for 
inducing osteogenesis. The majority of studies on Ti-implant-
surface treatments have focused on physicochemical surface 
modifications to improve osseointegration and interactions 
between surfaces and tissues. In the Ti-surface-modification 
method that has been reported, a special apparatus, such 
as a plasma spray apparatus, was required. However, the 
method described in this study constitutes a simple surface-
reforming method that mixes oxSWNHs, TBP-NHBP, 
and a drug together, followed by incubation of Ti with the 
mixed solution, which enables it to transport the function 
of the drug. Because oxSWNHs are capable of transporting 
various drugs, we believe that it will be possible to perform 
surface modifications of Ti by enabling the drug to support 
oxSWNHs/TBP–NHBP according to the clinical purpose. 
Our findings have provided a basis for the development of 
new biomaterials for use in dental implants and as osteoblast 
scaffolds for bone regeneration.
Conclusion
We have successfully developed a solid-phase drug-delivery 
system where oxSWNHs were immobilized on a base 
material using TBP-NHBP, a bispecific material-binding 
peptide combining functions of minTBP-1 and NHBP-1. 
Through the use of TBP-NHBP, oxSWNHs, which other-
wise could not be attached to Ti, were successfully immo-
bilized on the Ti surface. SEM was used to confirm the 
presence of oxSWNHs adsorbed onto the Ti surface, and 
a QCM was used to evaluate the binding process during 
oxSWNH adsorption. Moreover, we were able to impart the 
function of sustained drug release to a substrate by using 
oxSWNHs. The oxSWNHs/TBP-NHBP-immobilized Ti 
surface was nontoxic to cells and could be used to deliver 
DEX, an anti-inflammatory agent, over a sustained period. 
The released DEX was confirmed as biologically active, 
suggesting the potential use of oxSWNHs/TBP-NHBP as 
a drug-delivery system to stimulate osteogenesis and bone 
regeneration. Therefore, our findings suggested that surface 
modification is a useful approach for designing medical 
biomaterials with desirable properties and possible practi-
cal applications.
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